Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pastan

Showing results (561-570 of 689) with videos related to

Pageof 69
Sort By:
Cancer Research|July 4, 1998
Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized FvJ A Carrasquillo, L Lang, M Whatley, et al.
Cancer Research|July 1, 1989
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude miceJ W Pearson, D J FitzGerald, M C Willingham, et al.
Somatic Cell and Molecular Genetics|September 1, 1985
Translocation chromosome 7 of A431 cells contains amplification and rearrangement of EGF receptor gene responsible for production of variant mRNAJ H Hunts, N Shimizu, T Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptorL H Pai-Scherf, J Villa, D Pearson, et al.
Science (New York, N.Y.)|August 1, 2000
Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia functionS Kaneko, T Hikida, D Watanabe, et al.
The Prostate|September 6, 2001
GDEP, a new gene differentially expressed in normal prostate and prostate cancerP Olsson, T K Bera, M Essand, et al.
The Journal of Biological Chemistry|December 15, 1992
Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transportersS J Currier, S E Kane, M C Willingham, et al.
Cancer Research|June 30, 2001
Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activityM Onda, S Nagata, Y Tsutsumi, et al.
Reviews of Infectious Diseases|September 1, 1987
Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxinsS J Cryz, E Fürer, J C Sadoff, et al.
Biochemical and Biophysical Research Communications|January 15, 1990
Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporterS Tanaka, S J Currier, E P Bruggemann, et al.
Pageof 69

Showing results (561-570 of 689) with videos related to

Sort By:
Pageof 69
Cancer Research|July 4, 1998
Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized FvJ A Carrasquillo, L Lang, M Whatley, et al.
Cancer Research|July 1, 1989
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude miceJ W Pearson, D J FitzGerald, M C Willingham, et al.
Somatic Cell and Molecular Genetics|September 1, 1985
Translocation chromosome 7 of A431 cells contains amplification and rearrangement of EGF receptor gene responsible for production of variant mRNAJ H Hunts, N Shimizu, T Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptorL H Pai-Scherf, J Villa, D Pearson, et al.
Science (New York, N.Y.)|August 1, 2000
Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia functionS Kaneko, T Hikida, D Watanabe, et al.
The Prostate|September 6, 2001
GDEP, a new gene differentially expressed in normal prostate and prostate cancerP Olsson, T K Bera, M Essand, et al.
The Journal of Biological Chemistry|December 15, 1992
Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transportersS J Currier, S E Kane, M C Willingham, et al.
Cancer Research|June 30, 2001
Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activityM Onda, S Nagata, Y Tsutsumi, et al.
Reviews of Infectious Diseases|September 1, 1987
Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxinsS J Cryz, E Fürer, J C Sadoff, et al.
Biochemical and Biophysical Research Communications|January 15, 1990
Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporterS Tanaka, S J Currier, E P Bruggemann, et al.
Pageof 69